- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Phospho-ERBB3- Y1289 AntibodyPeptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP3708a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP3708a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Phospho-ERBB3- Y1289 Antibody - Product info | |
| Application | DB, WB
|
| Primary Accession | P21860 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 148098 Da |
Phospho-ERBB3- Y1289 Antibody - Additional info | |
| Gene ID 2065 | |
| Other Names ERBB3; HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; Tyrosine kinase-type cell surface receptor HER3 | |
| Target/Specificity This Phospho-ERBB3-Y1289 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 1275~1304 amino acids surrounding Y1289 of human ERBB3. | |
| Dilution DB~~1:500 WB~~1:1000WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions Phospho-ERBB3- Y1289 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
Phospho-ERBB3- Y1289 Antibody - Protein Information | |
| Name ERBB3 | |
| Synonyms HER3 | |
| Function Binds and is activated by neuregulins and NTAK. | |
| Cellular Location Isoform 1: Cell membrane; Single-pass type I membrane protein | |
| Tissue Location Epithelial tissues and brain. | |
Phospho-ERBB3- Y1289 Antibody - Related products
AP3708a: Phospho-ERBB3- Y1289 Antibody
AP7630a: ERBB3 Antibody (N-term)
RI11825: ERBB3 predesign siRNA
DC01074: Human ERBB3 cDNA Clone
BP3708a: Phospho-ERBB3-Y1289 Antibody Blocking Peptide
BP7630a: ErbB3 Antibody (N-term) Blocking Peptide
AJ1341a: HER3 (ErbB3) Antibody (C-term)
AJ1341b: HER3/ErbB3 Antibody Phospho (pY1289)
AF1376a: ERBB3 / HER3 Antibody
Phospho-ERBB3- Y1289 Antibody - Application data
-
Dot blot analysis of anti-Phospho-ERBB3 (Tyr1289) Antibody Phospho-specific Pab (Cat. #AP3708a) on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.
-
Western blot analysis of extracts from T47D cells,untreated or treated with NRG using Phospho-ErBB3(Tyr1289)(left) or ErBB3 antibody(right).
Phospho-ERBB3- Y1289 Antibody - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form.
REFERENCES
Huang, X., et al. Cancer Res. 70(3):1204-1214(2010) Pierce, B.L., et al. Hum. Hered. 69(3):193-201(2010) Li, D., et al. World J. Biol. Psychiatry 10 (4 PT 2), 595-598 (2009) Carr, E.J., et al. BMC Med. Genet. 10, 121 (2009) Zhang, Y., et al. BMC Cell Biol. 10, 78 (2009)